These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19506097)

  • 1. Treatment of chronic proteinuric kidney disease: what next?
    Benigni A; Remuzzi G
    Hypertension; 2009 Jul; 54(1):29-31. PubMed ID: 19506097
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease.
    Dhaun N; Macintyre IM; Melville V; Lilitkarntakul P; Johnston NR; Goddard J; Webb DJ
    Hypertension; 2009 Jul; 54(1):113-9. PubMed ID: 19506099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of endothelin receptor antagonism relate to the degree of renin-angiotensin system blockade in chronic proteinuric kidney disease.
    Dhaun N; Macintyre IM; Melville V; Lilitkarntakul P; Johnston NR; Goddard J; Webb DJ
    Hypertension; 2009 Sep; 54(3):e19-20. PubMed ID: 19652085
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease.
    Dhaun N; MacIntyre IM; Kerr D; Melville V; Johnston NR; Haughie S; Goddard J; Webb DJ
    Hypertension; 2011 Apr; 57(4):772-9. PubMed ID: 21357275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade.
    Goddard J; Johnston NR; Hand MF; Cumming AD; Rabelink TJ; Rankin AJ; Webb DJ
    Circulation; 2004 Mar; 109(9):1186-93. PubMed ID: 14981006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure target in chronic kidney disease and proteinuria as an effect modifier.
    Schrier RW; Lumlertgul N
    Ann Intern Med; 2011 Aug; 155(3):207-8; author reply 208. PubMed ID: 21810725
    [No Abstract]   [Full Text] [Related]  

  • 7. Addition of aliskiren to olmesartan ameliorates tubular injury in chronic kidney disease patients partly by reducing proteinuria.
    Nakamura T; Sato E; Amaha M; Kawagoe Y; Maeda S; Yamagishi S
    J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):122-7. PubMed ID: 21946392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure control, proteinuria and renal outcome in chronic renal failure.
    Ruilope LM; Campo C; Rodicio JL
    Curr Opin Nephrol Hypertens; 1998 Mar; 7(2):145-8. PubMed ID: 9529615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target blood pressure for antihypertensive therapy in patients with proteinuric renal disease.
    Hebert LA
    Curr Hypertens Rep; 1999 Oct; 1(5):454-60. PubMed ID: 10981105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure, proteinuria and nephropathy in Fabry disease.
    Jain G; Warnock DG
    Nephron Clin Pract; 2011; 118(1):c43-8. PubMed ID: 21071972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R
    Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure.
    Wühl E; Mehls O; Schaefer F;
    Kidney Int; 2004 Aug; 66(2):768-76. PubMed ID: 15253732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial hypertension and proteinuria in pediatric chronic kidney disease.
    Simonetti GD; Bucher BS; Tschumi S; Lava SA; Bianchetti MG
    Minerva Pediatr; 2012 Apr; 64(2):171-82. PubMed ID: 22495191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood pressure goal and antihypertensive therapy in chronic kidney disease].
    Rump LC
    Dtsch Med Wochenschr; 2014 Nov; 139(48):2453-7. PubMed ID: 25409404
    [No Abstract]   [Full Text] [Related]  

  • 16. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin receptor antagonists and their developing role in cardiovascular therapeutics.
    Dupuis J
    Can J Cardiol; 2000 Jul; 16(7):903-10. PubMed ID: 10934309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should diuretics always be included as initial antihypertensive management in early-stage CKD?
    Segura J; Ruilope LM
    Curr Opin Nephrol Hypertens; 2009 Sep; 18(5):392-6. PubMed ID: 19561495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure response to type A endothelin receptor antagonism in human obesity and diabetes mellitus.
    Han KA; Lteif AA; Mather KJ
    J Hum Hypertens; 2006 Oct; 20(10):798-800. PubMed ID: 16855627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.